U.S. Personal Products Stock News

In early June 2026, Samsara Inc. reported first-quarter revenue of US$478.84 million, up from US$366.88 million a year earlier, and moved from a net loss of US$22.12 million to net income of US$44.51 million, with basic and diluted earnings per share both improving from a loss of US$0.04 to earnings of US$0.08. The company also issued guidance pointing to continued revenue growth and ongoing GAAP profitability for the second quarter and full fiscal 2027, highlighting momentum in annual...

Wondering whether Onto Innovation at around US$274.76 is still reasonably priced after its strong run, or if you might be turning up late to the story. The stock has returned 6.2% over the past week, is down 9.9% over the past month, and sits on gains of 65.6% year to date and 191.3% over the past year, which can change how investors think about both upside and risk. Recent coverage around Onto Innovation has focused on its role within the semiconductor sector and how investors are reacting...

Swarmer (NasdaqCM:SWMR) and Powerus have signed a Memorandum of Understanding to integrate Swarmer’s drone autonomy software into air and maritime autonomous systems. The collaboration targets defense, counter UAS, border security, and critical infrastructure protection use cases. The agreement extends Swarmer’s technology beyond its core drone market into broader multi domain autonomous platforms. Swarmer, trading at $72.81 under ticker NasdaqCM:SWMR, is coming off strong recent share...

Recent performance snapshot Principal Financial Group (PFG) has drawn attention after recent share price moves, with the stock last closing at US$103.51. Investors are weighing this level against its recent returns, profitability profile, and current valuation signals. See our latest analysis for Principal Financial Group. The recent 2.3% 1 day share price return adds to a steady trend, with a 90 day share price return of 12.2% and a 5 year total shareholder return of 92.2%. This indicates...

At the 2026 American Thoracic Society conference held earlier this year, Insmed showcased encouraging post‑hoc Phase III data for Brinsupri, its first‑to‑market DPP‑1 inhibitor for non‑cystic fibrosis bronchiectasis, while also granting inducement stock awards to 103 new employees under its 2025 Inducement Plan. The combination of positive clinical signals for Brinsupri and expanded equity‑based hiring underscores Insmed’s effort to build both medical leadership and internal capabilities...

Cinemark Holdings reported that May 2026 delivered its highest-ever domestic box office results, supported by a varied film slate and strong turnout, especially from younger audiences. The company also achieved record food and beverage spending per guest, underlining how concession monetization is becoming an increasingly powerful earnings driver alongside ticket sales. Next, we’ll examine how this record May performance, particularly the surge in concession spending, may influence...

Wondering if Ulta Beauty at US$462.52 is starting to look like value or if the stock still has more risk priced in? This article breaks down what the current share price might be implying. The stock has had a rough patch recently, with the share price falling 11.1% over the last week, 13.1% over the last month, and 25.4% year to date. The return over the last year is a smaller decline of 1.0%, and the 3 and 5 year returns are gains of 10.4% and 39.3% respectively. These moves sit against a...

In early June 2026, Core Natural Resources released its latest investor presentation, reporting Q1 2026 revenue of US$1.10 billion, Adjusted EBITDA of US$179.9 million, net operating cash flow of US$119.4 million, free cash flow of US$55.5 million, and total liquidity of US$935.4 million. The company also returned US$47.0 million to shareholders in the quarter, underlining its focus on capital returns alongside maintaining substantial liquidity. We’ll now examine how this strong Q1 free cash...

Freshpet (FRPT) is back in focus after being flagged on June 3 as the consumer staples stock with the highest short interest, paired with recent insider share sales and, in contrast, constructive fundamental assessments. See our latest analysis for Freshpet. Despite the recent short interest spotlight and insider selling, Freshpet’s share price has fallen 18.2% over the past month and 40.4% over the past quarter, while the 1 year total shareholder return is down 39.2%. This suggests momentum...

Kinsale Capital Group recently reported mixed first-quarter results, with revenue rising year over year but coming in below analyst expectations, highlighting the challenges of insuring hard-to-place and higher-risk clients. This earnings outcome has prompted investors to reassess how Kinsale’s niche focus and underwriting approach might influence its longer-term business prospects. We’ll now explore how Kinsale’s revenue shortfall against expectations may influence its investment narrative...

Recent performance snapshot AerCap Holdings (AER) has drawn fresh attention after recent trading left the stock down about 6% over the past month, even as its past 3 months return is roughly flat. For investors tracking the aircraft leasing sector, this short term pullback sits against a backdrop of a 19% total return over the past year and multi year gains that are several times higher than that. See our latest analysis for AerCap Holdings. Recent trading shows momentum cooling, with the...

CSX (CSX) is drawing fresh attention after being named Nissan’s 2026 Supply Chain Management Partner of the Year, a recognition that sits alongside recent stock outperformance and improving full year earnings estimates. See our latest analysis for CSX. Beyond the Nissan recognition, CSX’s share price has been firming, with a 30 day share price return of 2.66% and a 90 day share price return of 15.72%. The 1 year total shareholder return of 47.71% points to strong momentum over a longer...

Event context and recent share performance MKS (MKSI) has drawn investor attention after recent share price moves, with the stock down 1.5% over the past day but up around 2.1% over the past week. See our latest analysis for MKS. While the 1-day share price return is down 1.47%, MKS has shown strong momentum recently, with a 30-day share price return of 14.80%, a 90-day share price return of 57.25%, and a 1-year total shareholder return of 280.91%. This points to shifting expectations around...

WD-40 Company recently announced a series of executive leadership appointments, including new roles for chief strategy and innovation officer, chief brand and marketing officer, president of the Americas, and chief accounting officer, aimed at strengthening alignment and supporting its long-term priorities. A key angle is the company’s decision to elevate innovation and brand leadership, explicitly tying these roles to AI and digital technologies to support future initiatives. Next, we’ll...

Rambus recently announced its DDR5 9600 Client Memory Module Chipset for future AI PCs, pairing a new Gen2 client clock driver with PMIC and SPD Hub components to support clocked DDR5 modules up to 9,600 MT/s. By tackling signal integrity, power delivery, and coordination directly on the module, Rambus is positioning its companion chips as a foundational building block for next-generation AI-enabled PCs and workstations. We’ll now examine how this DDR5 9600 client chipset launch for AI PCs...

Recently, analysts upgraded American States Water to a more favorable Zacks Rank #2 rating after raising earnings estimates over the past few months, signaling improved expectations for the utility’s profit outlook. This shift in analyst sentiment, rooted in steadily higher earnings forecasts, highlights how changing views on the company’s future profitability can materially influence investor interest. We’ll now examine how this analyst upgrade and improving earnings outlook interact with...

Conference appearance and recent stock momentum AMN Healthcare Services (AMN) heads into its June 3 presentation at the 46th Annual William Blair Growth Stock Conference with fresh attention on its Q1 2026 earnings results and recent share price performance. The company reported Q1 improvements in revenue, EBITDA, and earnings per share, which has drawn investor focus to the stock. For investors, the Chicago conference appearance offers another opportunity to hear from management following...

Fortune Brands Innovations (FBIN) has begun a formal review of options for its Fiberon composite decking business, with the goal of directing capital toward areas it views as offering higher potential returns. See our latest analysis for Fortune Brands Innovations. The Fiberon review comes after a period where the share price return has softened, with the stock down year to date and over the past year, while the 1 month share price return of 2.99% hints at some near term momentum. If you are...

In its most recent quarter, AZZ reported revenue growth of 9.4% year on year, beating analyst expectations and leading its commercial building products peers, while also disclosing a routine restricted stock unit conversion by its COO related to a prior equity award. This combination of strong operating performance in a mixed sector backdrop and ordinary-course insider equity vesting provides a clearer lens on how AZZ is executing operationally without signaling major shifts in insider...

What the Zacks Upgrade Signals for First Bancorp (FBNC) First Bancorp (FBNC) was recently upgraded to a Zacks Rank #2, reflecting higher earnings estimates and fresh attention on the stock. For investors, the key question is how this new sentiment lines up with current fundamentals. See our latest analysis for First Bancorp. The recent Zacks upgrade comes as the stock trades at US$59.43, with a 1-day share price return of 3.70% and a 1-year total shareholder return of 47.72%, suggesting that...

Hinge Health (NYSE:HNGE) released a landmark medical claims study on its digital musculoskeletal program. The analysis covers five years of data from more than 200,000 participants across 1,000 employers. Results show an average annual cost savings of US$2,941 per member, fewer surgeries, injections, and imaging, and a reported 3.0x+ ROI over several years. The study is described as the company’s largest and most comprehensive independent validation to date. Hinge Health focuses on digital...

Medpace Holdings (MEDP) is back in focus after several law firms highlighted upcoming deadlines for investors in securities class action lawsuits, keeping attention on allegations around backlog cancellations and growth expectations. See our latest analysis for Medpace Holdings. At a latest share price of US$458.69, Medpace has a 1 month share price return of 6.6% and a year to date share price return that is down 19.7%, while the 1 year total shareholder return of 56.2% points to stronger...

Byline Bancorp recently filed a shelf registration for up to US$63.40 million, covering 1,897,594 shares of common stock for a potential ESOP-related offering. This move gives the bank added flexibility to support its employee ownership plan, which can influence capital allocation, dilution, and long-term incentives for staff. We’ll now examine how this potential ESOP-related equity issuance could shape Byline Bancorp’s investment narrative and capital management outlook. Invest in the...

Carlyle’s governance shift and what it could mean for investors Carlyle Group (CG) is pairing a leadership change in its legal function with a clearer public focus on national defense, energy security, and data protection as key private capital themes. Incoming General Counsel Kate Heinzelman, previously the Central Intelligence Agency’s chief legal officer, will oversee Carlyle’s global legal and compliance organization while reporting directly to Chief Executive Officer Harvey Schwartz. See...